U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
GRESONITAMAB
INN  
Official Name English
IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN CLAUDIN 18.2) (HUMAN MONOCLONAL HWZV_KLA_L SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HU
Common Name English
gresonitamab [INN]
Common Name English
AMG 910 [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 752720
Created by admin on Sat Dec 16 15:15:59 GMT 2023 , Edited by admin on Sat Dec 16 15:15:59 GMT 2023
Code System Code Type Description
INN
11798
Created by admin on Sat Dec 16 15:15:59 GMT 2023 , Edited by admin on Sat Dec 16 15:15:59 GMT 2023
PRIMARY
NCI_THESAURUS
C184829
Created by admin on Sat Dec 16 15:15:59 GMT 2023 , Edited by admin on Sat Dec 16 15:15:59 GMT 2023
PRIMARY
FDA UNII
0SIB91V6TP
Created by admin on Sat Dec 16 15:15:59 GMT 2023 , Edited by admin on Sat Dec 16 15:15:59 GMT 2023
PRIMARY
CAS
2413817-97-5
Created by admin on Sat Dec 16 15:15:59 GMT 2023 , Edited by admin on Sat Dec 16 15:15:59 GMT 2023
PRIMARY
ACTIVE MOIETY
GRESONITAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966